Sidley advises on the initial public offering of Concord Healthcare Group Co., Ltd. in Hong Kong.

Sidley advised on the initial public offering and listing of the H shares of Concord Healthcare Group Co., Ltd. (HKEX: 2453) (Concord Healthcare Group) on the Main Board of the Hong Kong Stock Exchange (HKEX). The offering raised around HK$562.9 million (US$72.2 million). Sidley acted as Hong Kong and US advisors to joint sponsors China International Capital Corporation Hong Kong Securities Limited, Haitong International Capital Limited and the underwriters.

Concord Healthcare Group is an oncology healthcare provider in China. The Company serves both cancer patients through its own medical facilities and external medical facilities through its medical equipment, software and related services. Through its own medical facilities, the company offers cancer patients a full range of oncology healthcare services, leveraging its multidisciplinary team of specialists and diagnostic and treatment options, including precision radiation therapy.

The Sidley team was led by partners Meng Ding and Claudia Yu. Other team members included senior associate Kevin Chan, associates Maggie Bai and Yiming Chen, China advisor Junlang Chen, legal manager Lexie Lu and senior legal assistants Iris Lao, Freddie Feng, Alice Liu and Luting Cui.